Exact Mass: 359.1456686
Exact Mass Matches: 359.1456686
Found 70 metabolites which its exact mass value is equals to given mass value 359.1456686,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Capecitabine
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite CONFIDENCE standard compound; EAWAG_UCHEM_ID 2845 D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.
N-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
Chlorambucil-tertiary butyl ester
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
Oxodipine
C19H21NO6 (359.13688060000004)
N-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enamide
C19H21NO6 (359.13688060000004)
6-Aethansulfinyl-3-methoxy-17-methyl-morphina-5,7-dien-4-ol|6-ethanesulfinyl-3-methoxy-17-methyl-morphina-5,7-dien-4-ol
C20H25NO3S (359.15550600000006)
2-Butyl-5-methoxy-7-phenyl-1H-benzo[de]isoquinoline-1,6(2H)-dione
C23H21NO3 (359.15213560000007)
3-O-acetylungiminorine|3-O-Acetylungminorine|ungiminorine acetate
C19H21NO6 (359.13688060000004)
4,6,7-Trimethoxy-5-(2-hydroperoxy-3-methyl-3-butenyl)furo[2,3-b]quinoline
C19H21NO6 (359.13688060000004)
(E)-1,1-dimethyl-3-(4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl)-2-propenyl hydroperoxide
C19H21NO6 (359.13688060000004)
2-methoxycassiarin B-3-one|cassiarin H
C19H21NO6 (359.13688060000004)
(+)-3alpha-methoxy-6beta-acetylbulbispermine
C19H21NO6 (359.13688060000004)
Capecitabine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 2353 INTERNAL_ID 2353; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2140 CONFIDENCE standard compound; INTERNAL_ID 8343 CONFIDENCE standard compound; INTERNAL_ID 4129 Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.
[1-(4-methoxyanilino)-1-oxopropan-2-yl] 6-oxo-1-propylpyridazine-3-carboxylate
C18H21N3O5 (359.14811360000004)
http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 16
(S)-1,2,3,4-tetrahydro-1-phenylisoquinoline D-(-)-tartrate
C19H21NO6 (359.13688060000004)
5-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine
DIETHYL 1-BENZYL-3,4-ETHYLENEDIOXYPYRRO&
C19H21NO6 (359.13688060000004)
(4-(N-(2-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)SULFAMOYL)PHENYL)BORONIC ACID
(5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone - 1 ,1-diphenylmethanamine (1:1) (non-preferred name)
C19H21NO6 (359.13688060000004)
2,6-difluoro-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide
Oxodipine
C19H21NO6 (359.13688060000004)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(4-BENZYLPIPERAZIN-1-YL)PIPERIDIN-4-YL-METHANONE DIHYDROCHLORIDE
5-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine
5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine is an impurity in the synthesis of Capecitabine (HY-B0016)[1].
methyl 2-[5-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxo-2-phenylpyrimidin-1-yl]acetate
C18H21N3O5 (359.14811360000004)
(S)-(+)-5-OXOTETRAHYDROFURAN-2-CARBOXYLICACID
C23H21NO3 (359.15213560000007)
Isopropyl 2-[4-(3-chlorophenyl)piperazino]nicotinate
C19H22ClN3O2 (359.14004620000003)
N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(2-methylphenyl)-1-phenylpyrazole-4-carboxamide
N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide
C17H21N5O2S (359.14158860000003)
5-[1-[(3,5-Dimethoxyphenyl)methylamino]ethylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione
C18H21N3O5 (359.14811360000004)
N-[2-[(2-methylphenyl)methylthio]ethyl]-3-[(4-methylphenyl)thio]propanamide
1-(4-Chlorophenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]urea
C19H22ClN3O2 (359.14004620000003)
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[(4-methylphenyl)thio]propanamide
C20H25NO3S (359.15550600000006)
N-[2-(4-Methoxy-phenyl)-6-methyl-2H-benzotriazol-5-yl]-nicotinamide
[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]-(2-ethoxy-3-pyridinyl)methanone
C19H22ClN3O2 (359.14004620000003)
N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-cyclopropyl-4-thiadiazolecarboxamide
C17H21N5O2S (359.14158860000003)
AVN-492
C17H21N5O2S (359.14158860000003)
AVN-492 is a very specific and highly-selective antagonist with picomolar affinity to 5-HT6R (Ki=91 pM).
(1s,16r,17s,18s,19s)-16-hydroxy-17-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,14-tetraen-18-yl acetate
C19H21NO6 (359.13688060000004)
3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-1h,2h,3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid
C15H25N3O5S (359.15148400000004)
(2e)-n-[(2r)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
(1r,9r,10s)-3,6-dihydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-8,13-dione
C19H21NO6 (359.13688060000004)
3-butyl-7-methoxy-10-phenyl-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,6,9(13),10-pentaene-2,8-dione
C23H21NO3 (359.15213560000007)
(2r)-3-methyl-1-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
(2e)-n-[(2s)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
7-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethylisoquinolin-8-ol
C23H21NO3 (359.15213560000007)
(1r,11s,13s,15r,18s)-18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate
C19H21NO6 (359.13688060000004)
n-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
(9bs,11r,12r)-12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione
C19H21NO6 (359.13688060000004)
17-hydroxy-14-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate
C19H21NO6 (359.13688060000004)
2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
methyl 4-[(3s)-3-methoxy-3,7-dimethyl-4,11-dioxo-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),7,9-tetraen-6-yl]butanoate
C19H21NO6 (359.13688060000004)
12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione
C19H21NO6 (359.13688060000004)
(3e)-2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate
C19H21NO6 (359.13688060000004)